A post-entry role for CD63 in early HIV-1 replication

Virology

Volumn 412, Issue 2, 2011, Pages 315-324

  Li, Guangyu ^a   Dziuba, Natallia ^a   Friedrich, Brian ^a   Murray, James L ^b   Ferguson, Monique R ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b Zirus Inc   (United States)

Author keywords

CD63; HIV 1; Life cycle; Macrophage; SiRNA; Tetraspanin

Indexed keywords

CD4 ANTIGEN; CD63 ANTIGEN; COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; INTEGRASE INHIBITOR; MESSENGER RNA; RALTEGRAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SMALL INTERFERING RNA; TRANSACTIVATOR PROTEIN; ZIDOVUDINE;

ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; CD4+ T LYMPHOCYTE; CELL FUSION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LIFE CYCLE; LONG TERMINAL REPEAT; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRION; VIRUS ATTACHMENT; VIRUS DNA CELL DNA INTERACTION; VIRUS REPLICATION; WESTERN BLOTTING;

ANTIGENS, CD; ANTIGENS, CD63; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; HIV CORE PROTEIN P24; HIV-1; HUMANS; MACROPHAGES; PLATELET MEMBRANE GLYCOPROTEINS; REVERSE TRANSCRIPTION; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; VIRUS INTEGRATION; VIRUS INTERNALIZATION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79952631349     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.01.017     Document Type: Article

References (54)

1. Aiken C. Viral and cellular factors that regulate HIV-1 uncoating. Curr. Opin. HIV AIDS 2006, 1:194-199.
2. Arts E.J., Wainberg M.A. Preferential incorporation of nucleoside analogs after template switching during human immunodeficiency virus reverse transcription. Antimicrob. Agents Chemother. 1994, 38(5):1008-1016.
3. Bergamaschi A., Pancino G. Host hindrance to HIV-1 replication in monocytes and macrophages. Retrovirology 2010, 7:31.
4. Bol S.M., van Remmerden Y., Sietzema J.G., Kootstra N.A., Schuitemaker H., van't Wout A.B. Donor variation in in vitro HIV-1 susceptibility of monocyte-derived macrophages. Virology 2009, 390:205-211.
5. Bouazzaoui A., Kreutz M., Eisert V., Dinauer N., Heinzelmann A., Hallenberger S., Strayle J., Walker R., Rubsamen-Waigmann H., Andreesen R., von Briesen H. Stimulated trans-acting factor of 50kDa (Staf50) inhibits HIV-1 replication in human monocyte-derived macrophages. Virology 2006, 356:79-94.
6. Brass A.L., Dykxhoorn D.M., Benita Y., Yan N., Engelman A., Xavier R.J., Lieberman J., Elledge S.J. Identification of host proteins required for HIV infection through a functional genomic screen. Science 2008, 319(5865):921-926.
7. Bukrinsky M., Sharova N., Stevenson M. Human immunodeficiency virus type 1 2-LTR circles reside in a nucleoprotein complex which is different from the preintegration complex. J. Virol. 1993, 67:6863-6865.
8. Butler S.L., Hansen M.S., Bushman F.D. A quantitative assay for HIV DNA integration in vivo. Nat. Med. 2001, 7:631-634.
9. Chang J., Naif H.M., Li S., Sullivan J.S., Randle C.M., Cunningham A.L. Twin studies demonstrate a host cell genetic effect on productive human immunodeficiency virus infection of human monocytes and macrophages in vitro. J. Virol. 1996, 70:7792-7803.
10. Chen H., Dziuba N., Friedrich B., von Lindern J., Murray J.L., Rojo D.R., Hodge T.W., O'Brien W.A., Ferguson M.R. A critical role for CD63 in HIV replication and infection of macrophages and cell lines. Virology 2008, 379(2):191-196.
11. Chertova E., Chertov O., Coren L.V., Roser J.D., Trubey C.M., Bess J.W., Sowder R.C., Barsov E., Hood B.L., Fisher R.J., Nagashima K., Conrads T.P., Veenstra T.D., Lifson J.D., Ott D.E. Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J. Virol. 2006, 80(18):9039-9052.
12. Dragic T., Litwin V., Allaway G.P., Martin S.R., Huang Y., Nagashima K.A., Cayanan C., Maddon P.J., Koup R.A., Moore J.P., Paxton W.A. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996, 381(6584):667-673.
13. Eisert V., Kreutz M., Becker K., Königs C., Alex U., Rübsamen-Waigmann H., Andreesen R., von Briesen H. Analysis of cellular factors influencing the replication of human immunodeficiency virus type I in human macrophages derived from blood of different healthy donors. Virology 2001, 286:31-44.
14. Farnet C.M., Haseltine W.A. Circularization of human immunodeficiency virus type 1 DNA in vitro. J. Virol. 1991, 65:6942-6952.
15. Feng Y., Broder C.C., Kennedy P.E., Berger E.A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996, 272(5263):872-877.
16. Friedrich B., Li G., Dziuba N., Ferguson M.R. Quantitative PCR used to assess HIV-1 integration and 2-LTR circle formation in human macrophages, peripheral blood lymphocytes and a CD4+ cell line. Virol. J. 2010, 7:354.
17. Goodarzi G., Pursley M., Felock P., Witmer M., Hazuda D., Brackmann K., Grandgenett D. Efficiency and fidelity of full-site integration reactions using recombinant simian immunodeficiency virus integrase. J. Virol. 1999, 73(10):8104-8111.
18. Greene W.C. The molecular biology of human immunodeficiency virus type 1 infection. N. Engl. J. Med. 1991, 324(5):308-317.
19. Grigorov B., Arcanger F., Roingeard P., Darlix J.L., Muriaux D. Assembly of infectious HIV-1 in human epithelial and T-lymphoblastic cell lines. J. Mol. Biol. 2006, 359(4):848-862.
20. Hamamoto S., Nishitsuji H., Amagasa T., Kannagi M., Masuda T. Identification of a novel human immunodeficiency virus type 1 integrase interactor, Gemin2, that facilitates efficient viral cDNA synthesis in vivo. J. Virol. 2006, 80(12):5670-5677.
21. Harrington R.D., Geballe A.P. Cofactor requirement for human immunodeficiency virus type 1 entry into a CD4-expressing human cell line. J. Virol. 1993, 67:5939-5947.
22. Hemler M.E. Tetraspanin functions and associated microdomains. Nat. Rev. Mol. Cell Biol. 2005, 6:801-811.
23. Hooker C.W., Harrich D. The first strand transfer reaction of HIV-1 reverse transcription is more efficient in infected cells than in cell-free natural endogenous reverse transcription reactions. J. Clin. Virol. 2003, 26(2):229-238.
24. Hughes A., Barber T., Nelson M. New treatment options for HIV salvage patients: an overview of second generation PIs, NNRTIs, integrase inhibitors and CCR5 antagonists. J. Infect. 2008, 57(1):1-10.
25. Jolly C., Sattentau Q.J. Human immunodeficiency virus type 1 assembly, budding, and cell-cell spread in T cells take place in tetraspanin-enriched plasma membrane domains. J. Virol. 2007, 81(15):7873-7884.
26. Klatzmann D., Champagne E., Chamaret S., Gruest J., Guetard D., Hercend T., Gluckman J.C., Montagnier L. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 1984, 312(5996):767-768.
27. Krementsov D.N., Weng J., Labele M., Roy N.H., Thali M. Tetraspanins regulate cell-to-cell transmission of HIV-1. Retrovirology 2009, 6:64.
28. Krishnan V., Zeichner S.L. Alterations in the expression of DEAD-box and other RNA binding proteins during HIV-1 replication. Retrovirology 2004, 1:42.
29. Kumar A., Zloza A., Moon R.T., Watts J., Tenorio A.R., Al-Harthi L. Active beta-catenin signaling is an inhibitory pathway for human immunodeficiency virus replication in peripheral blood mononuclear cells. J. Virol. 2008, 82(6):2813-2820.
30. Lin D., Kamsteeg E.J., Zhang Y., Jin Y., Sterling H., Yue P., Roos M., Duffield A., Spencer J., Caplan M., Wang W.H. Expression of tetraspan protein CD63 activates protein-tyrosine kinase (PTK) and enhances the PTK-induced inhibition of ROMK channels. J. Biol. Chem. 2008, 283(12):7674-7681.
31. Morita E., Sundquist W.I. Retrovirus budding. Annu. Rev. Cell Dev. Biol. 2004, 20:395-425.
32. Murray J.L., Mavrakis M., McDonald N.J., Yilla M., Sheng J., Bellini W.J., Zhao L., Le Doux J.M., Shaw M.W., Luo C.C., Lippincott-Schwartz J., Sanchez A., Rubin D.H., Hodge T.W. Rab9 GTPase is required for replication of human immunodeficiency virus type 1, filoviruses, and measles virus. J. Virol. 2005, 79(18):11742-11751.
33. Nydegger S., Khurana S., Krementsov D.N., Foti M., Thali M. Mapping of tetraspanin-enriched microdomains that can function as gateways for HIV-1. J. Cell Biol. 2006, 173(5):795-807.
34. O'Brien W.A., Koyanagi Y., Namazie A., Zhao J.Q., Diagne A., Idler K., Zack J.A., Chen I.S. HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain. Nature 1990, 348:69-73.
35. O'Doherty U., Swiggard W.J., Jeyakumar D., McGain D., Malim M.H. A sensitive, quantitative assay for human immunodeficiency virus type 1 integration. J. Virol. 2002, 76:10942-10950.
36. Pelchen-Matthews A., Kramer B., Marsh M. Infectious HIV-1 assembles in late endosomes in primary macrophages. J. Cell Biol. 2003, 162(3):443-455.
37. Perlman M., Resh M.D. Identification of an intracellular trafficking and assembly pathway for HIV-1 gag. Traffic 2006, 7(6):731-745.
38. Popik W., Pitha P.M. Binding of human immunodeficiency virus type 1 to CD4 induces association of Lck and Raf-1 and activates Raf-1 by a Ras-independent pathway. Mol. Cell. Biol. 1996, 16:6532-6541.
39. Raposo G., Moore M., Innes D., Leijendekker R., Leigh-Brown A., Benaroch P., Geuze H. Human macrophages accumulate HIV-1 particles in MHC II compartments. Traffic 2002, 3(10):718-729.
40. Reeves J.D., Piefer A.J. Emerging drug targets for antiretroviral therapy. Drugs 2005, 65(13):1747-1766.
41. Rich E.A., Chen I.S., Zack J.A., Leonard M.L., O'Brien W.A. Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1). J. Clin. Invest. 1992, 89:176-183.
42. Rous B.A., Reaves B.J., Ihrke G., Briggs J.A., Gray S.R., Stephens D.J., Banting G., Luzio J.P. Role of adaptor complex AP-3 in targeting wild-type and mutated CD63 to lysosomes. Mol. Biol. Cell 2002, 13(3):1071-1082.
43. Ruiz-Mateos E., Pelchen-Matthews A., Deneka M., Marsh M. CD63 is not required for production of infectious human immunodeficiency virus type 1 in human macrophages. J. Virol. 2008, 82(10):4751-4761.
44. Sato K., Aoki J., Misawa N., Daikoku E., Sano K., Tanaka Y., Koyanagi Y. Modulation of human immunodeficiency virus type 1 infectivity through incorporation of tetraspanin proteins. J. Virol. 2008, 82(2):1021-1033.
45. Stipp C.S., Kolesnikova T.V., Hemler M.E. Functional domains in tetraspanin proteins. Trends Biochem. Sci. 2003, 28(2):106-112.
46. Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004, 427(6977):848-853.
47. Tanaka M., Ueno T., Nakahara T., Sasaki K., Ishimoto A., Sakai H. Downregulation of CD4 is required for maintenance of viral infectivity of HIV-1. Virology 2003, 311(2):316-325.
48. Ugolini S., Mondor I., Parren P.W., Burton D.R., Tilley S.A., Klasse P.J., Sattentau Q.J. Inhibition of virus attachment to CD4+ target cells is a major mechanism of T cell line-adapted HIV-1 neutralization. J. Exp. Med. 1997, 186(8):1287-1298.
49. Vodicka M.A., Goh W.C., Wu L.I., Rogel M.E., Bartz S.R., Schweickart V.L., Raport C.J., Emerman M. Indicator cell lines for detection of primary strains of human and simian immunodeficiency viruses. Virology 1997, 233:193-198.
50. von Lindern J.J., Rojo D., Grovit-Ferbas K., Yeramian C., Deng C., Herbein G., Ferguson M.R., Pappas T.C., Decker J.M., Singh A., Collman R.G., O'Brien W.A. Potential role for CD63 in CCR5-mediated human immunodeficiency virus type 1 infection of macrophages. J. Virol. 2003, 77(6):3624-3633.
51. von Schwedler U.K., Stuchell M., Müller B., Ward D.M., Chung H.Y., Morita E., Wang H.E., Davis T., He G.P., Cimbora D.M., Scott A., Kräusslich H.G., Kaplan J., Morham S.G., Sundquist W.I. The protein network of HIV budding. Cell 2003, 114(6):701-713.
52. Warrilow D., Meredith L., Davis A., Burrell C., Li P., Morita E., Wang H.E., Harrich D. Cell factors stimulate human immunodeficiency virus type 1 reverse transcription in vitro. J. Virol. 2008, 82(3):1425-1437.
53. Warrilow D., Warren K., Harrich D. Strand transfer and elongation of HIV-1 reverse transcription is facilitated by cell factors in vitro. PLoS ONE 2010, 5(10):e13229.
54. Zack J.A., Arrigo S.J., Weitsman S.R., Go A.S., Haislip A., Chen I.S. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 1990, 61:213-222.